Detection of Common Respiratory Infections, Including COVID-19, Using Consumer Wearable Devices in Health Care Workers: Prospective Model Validation Study.

Detection of Common Respiratory Infections, Including COVID-19, Using Consumer Wearable Devices in Health Care Workers: Prospective Model Validation Study.

Publication date: Jul 17, 2024

The early detection of respiratory infections could improve responses against outbreaks. Wearable devices can provide insights into health and well-being using longitudinal physiological signals. The purpose of this study was to prospectively evaluate the performance of a consumer wearable physiology-based respiratory infection detection algorithm in health care workers. In this study, we evaluated the performance of a previously developed system to predict the presence of COVID-19 or other upper respiratory infections. The system generates real-time alerts using physiological signals recorded from a smartwatch. Resting heart rate, respiratory rate, and heart rate variability measured during the sleeping period were used for prediction. After baseline recordings, when participants received a notification from the system, they were required to undergo testing at a Northwell Health System site. Participants were asked to self-report any positive tests during the study. The accuracy of model prediction was evaluated using respiratory infection results (laboratory results or self-reports), and postnotification surveys were used to evaluate potential confounding factors. A total of 577 participants from Northwell Health in New York were enrolled in the study between January 6, 2022, and July 20, 2022. Of these, 470 successfully completed the study, 89 did not provide sufficient physiological data to receive any prediction from the model, and 18 dropped out. Out of the 470 participants who completed the study and wore the smartwatch as required for the 16-week study duration, the algorithm generated 665 positive alerts, of which 153 (23. 0%) were not acted upon to undergo testing for respiratory viruses. Across the 512 instances of positive alerts that involved a respiratory viral panel test, 63 had confirmed respiratory infection results (ie, COVID-19 or other respiratory infections detected using a polymerase chain reaction or home test) and the remaining 449 had negative upper respiratory infection test results. Across all cases, the estimated false-positive rate based on predictions per day was 2%, and the positive-predictive value ranged from 4% to 10% in this specific population, with an observed incidence rate of 198 cases per week per 100,000. Detailed examination of questionnaires filled out after receiving a positive alert revealed that physical or emotional stress events, such as intense exercise, poor sleep, stress, and excessive alcohol consumption, could cause a false-positive result. The real-time alerting system provides advance warning on respiratory viral infections as well as other physical or emotional stress events that could lead to physiological signal changes. This study showed the potential of wearables with embedded alerting systems to provide information on wellness measures.

Open Access PDF

Concepts Keywords
Infections algorithm
July COVID detection
Smartwatch COVID-19
emotional stress
health
health care worker
infection
physical stress
physiology
prediction
respiratory infection
respiratory virus
respiratory virus detection
wearable
wearable device
well-being

Semantics

Type Source Name
disease MESH Respiratory Infections
disease MESH COVID-19
disease MESH infection
disease IDO algorithm
disease VO time
disease IDO site
disease VO report
disease VO Viruses
disease VO population
disease MESH emotional stress
drug DRUGBANK Ethanol
disease MESH viral infections
drug DRUGBANK Coenzyme M
disease VO device
disease IDO symptom
disease VO Gap
disease MESH influenza
drug DRUGBANK Etoperidone
disease VO vaccinated
disease VO dose
disease VO vaccine
disease VO vaccination
disease VO protocol
disease VO laboratory test
disease MESH shivering
disease MESH Sore throat
disease MESH chronic condition
disease VO nose
disease MESH allergies
disease VO Respiratory syncytial virus
disease VO Metapneumovirus
disease MESH parainfluenza
disease VO Enterovirus
drug DRUGBANK Caffeine
disease MESH sleep quality
disease MESH emphysema
disease MESH bronchitis
disease MESH arthritis
pathway REACTOME Immune System
disease MESH common cold
disease MESH uncertainty
disease VO stomach
disease MESH shingles
disease VO Optaflu
disease MESH eye infection
disease MESH death
disease MESH long COVID
disease MESH comorbidity
disease MESH infectious diseases
drug DRUGBANK Alpha-1-proteinase inhibitor
disease IDO process
disease MESH emergency
disease IDO host
disease VO USA
disease VO Algenpantucel-L Vaccine
disease VO Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen

Original Article

(Visited 2 times, 1 visits today)